Early lung cancer coopts immune cell into helping tumors invade the lungs
2021-06-16
(Press-News.org) New York, NY (June 16, 2021) -- Immune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature in June.
The researchers found that early-stage lung cancer tumors coopt the immune cells, known as tissue-resident macrophages, to help invade lung tissue. They also mapped out the process, or program, of how the macrophages allows a tumor to hurt the tissues the macrophage normally repairs. This process allows the tumor to hide from the immune system and proliferate into later, deadly stages of cancer.
Macrophages play a key role in shaping the tumor microenvironment, the ecosystem that surrounds tumors in the body. By investigating this microenvironment, researchers can find key players that drive tumor growth that can be tested as targets for immunotherapy. But modifying macrophages therapeutically has proven difficult.
In this study, scientists studied tissue samples from lung cancer tumors and surrounding lung tissue in 35 patients to see the role of macrophages in the development of the tumors.
The study's lead author, Miriam Merad, MD, PhD, Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai, and a multidisciplinary team of thoracic surgeons, pathologists, and medical oncologists within the Institute of Thoracic Oncology devised a comprehensive study that began when patients went into surgery to have cancerous lesions removed. The patients' lung tumor samples, samples of surrounding healthy lung tissue, and blood samples were immediately analyzed on a cellular level at Mount Sinai's Human Immune Monitoring Center to map out the immune system components they contained.
Researchers identified the macrophages at play in the early development of lung cancer, identifying a potential target for future drug development. They also found that the process that allows the macrophages to help tumors invade lung tissues is present in mice as well, which will allow them to manipulate the macrophages in future mouse models knowing that the manipulation is relevant to humans.
Half of all early-stage lung cancers relapse, and once they do and reach later stages, it is deadly and irreversible. Knowing how to attack the cancer at an early stage could have huge impacts on the number of patients relapsing and their overall survival.
"These findings are very important for Mount Sinai in the future as we have a very strong lung cancer screening program that identifies patients with early lung cancer lesions before they become fully invasive," said Dr. Merad, who is also the Director of the Human Immune Monitoring Center and a member of the Institute of Thoracic Oncology and The Tisch Cancer Institute at Mount Sinai. "These findings will help devise immunoprevention strategies to prevent tumor progression in patients at risk by reprogramming macrophages and killing the tumor without surgery."
INFORMATION:
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care--from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-16
June 16, 2021, CLEVELAND: New findings from Cleveland Clinic researchers show for the first time that the gut microbiome impacts stroke severity and functional impairment following stroke. The results, published in Cell Host & Microbe, lay the groundwork for potential new interventions to help treat or prevent stroke.
The research was led by Weifei Zhu, Ph.D., and Stanley Hazen, M.D., Ph.D., of Cleveland Clinic's Lerner Research Institute. The study builds on more than a decade of research spearheaded by Dr. Hazen and his team related to the gut microbiome's role in cardiovascular health and disease, including the adverse effects of TMAO (trimethylamine N-oxide) - a byproduct produced when gut bacteria digest certain nutrients abundant in red meat and other animal ...
2021-06-16
Our eyes move three times per second. Every time we move our eyes, the world in front of us flies across the retina at the back of our eyes, dramatically shifting the image the eyes send to the brain; yet, as far as we can tell, nothing appears to move. A new study provides new insight into this process known as "visual stabilization". The results are published in the Proceedings of the National Academy of Sciences.
"Our results show that a framing strategy is at work behind the scenes all the time, which helps stabilize our visual experience," says senior author Patrick Cavanagh, a research professor in psychological and brain sciences at Dartmouth ...
2021-06-16
A joint paper went out in Journal of Petroleum Science and Engineering.
Petroleum, being a liquid compound, has very good migratory properties, and recovery methods take account of that - using various methods, oilers displace petroleum through cavities and vugs and extract it. However, sometimes oil is "locked" in low-permeability reservoirs, and water displacement used in such cases poses a high risk of reservoir flooding and workplace emergencies.
Many teams work on blocking high-permeability areas in order to make extraction a more controlled and safe process. In particular, there have yet been no efficient agents for reservoirs with high temperatures (up to 140 C) and mineralization (up to 250 grams ...
2021-06-16
Professor Hermann Ehrlich places a piece of sponge in an alkaline, copper-containing ammonia solution that simulates a copper bath from the manufacture of circuit boards for electronic components. About 12 hours later the sponge has turned blue - when dry it is stronger than before, but still very light. "At a pH value of 9 the fibers of the spongin open and the organic compounds of the protein change," explains Prof. Hermann Ehrlich. The copper contained in the ammonia solution reacts immediately with the organic components of the spongin, especially with the amino acid residues, and forms the mineral atacamite. "Like a string, nanometer-sized crystals grow along with the spongin fiber," explains the scientist. ...
2021-06-16
Olives, well-known for their characteristic bitter taste, are in high demand owing to the popularity of the oil that's derived from them. The health benefits of olive oil are well known, ranging from antiviral, anti-cancer, to even anti-hypertensive effects. These benefits are attributed to "oleuropein," the most abundant olive secoiridoid found in olives.
An efficient method to enhance the quality of plant products is by using molecular methods to manipulate their genes and enhancing their yield. With olives, however, this is still a challenge, because of a lack of sufficient genome data.
So far, the genomes of two European olive varieties have been sequenced. But to fully decipher ...
2021-06-16
Lack of data on contraception uptake prior to the pandemic means no clear picture of the impact Covid-19 had on contraception use
Study from Warwick Medical School highlights need to maintain access to contraception during disasters
Researchers recommend making more contraception prescription-free and discuss the benefits and pitfalls of telehealth
Limited data on the uptake of contraception prior to and during crises such as the Covid-19 pandemic could mean unforeseen issues for sexual and reproductive health services, research from the University of Warwick concludes.
It identifies additional barriers that women faced in accessing contraception during the Covid-19 lockdown, including disruption to sexual health services and fears about contracting the virus, as ...
2021-06-16
New research shows the UK's COVID-19 management decisions were based on an outdated pandemic modelling structure and suggests a more resilient approach would have been more effective.
In the initial months of the pandemic, regular updates using graphs showing how the R number was behaving was the mainstay of the Government's strategy for tackling COVID-19.
This type of infection transmission is usually mathematically-based on dividing the population into 'compartments'. Such an approach has been criticised for its limited scope and inability to capture critical factors, such as the ...
2021-06-16
Results show BAT's Modern Oral nicotine pouches have a comparable toxicant profile to NRTs, which are currently considered the least risky of all nicotine products*†
The Modern Oral products have far fewer and significantly lower levels of toxicants‡ than cigarette smoke
Data demonstrates how BAT is building A Better Tomorrow™ by providing evidence to show how we are reducing the health impact of our business and delivering Tobacco Harm Reduction
London, 16 June: New research published today indicates that BAT's modern oral (MO) products in the form of tobacco-free nicotine pouches have a toxicant profile that is comparable to nicotine replacement therapies (NRTs) and much lower than traditional oral ...
2021-06-16
CHAPEL HILL, NC - UNC School of Medicine scientists led a collaboration of researchers to demonstrate a potentially powerful new strategy for treating cystic fibrosis (CF) and potentially a wide range of other diseases. It involves small, nucleic acid molecules called oligonucleotides that can correct some of the gene defects that underlie CF but are not addressed by existing modulator therapies. The researchers used a new delivery method that overcomes traditional obstacles of getting oligonucleotides into lung cells.
As the scientists reported in the journal Nucleic Acids Research, they demonstrated the striking effectiveness of their approach in cells derived from a CF patient and in mice.
"With our oligonucleotide delivery platform, we were able to restore the activity of ...
2021-06-16
Stuttgart/Boulder - It is not the first time that spiders have served as biological models in the research field of soft robotics. The hydraulic actuation mechanisms they apply to move their limbs when weaving their web or hunting for prey give them powers many roboticists and engineers have drawn inspiration from.
A team of researchers at the Max Planck Institute for Intelligent Systems in Germany and at the University of Boulder in Colorado in the US has now found a new way to exploit the principles of spiders' joints to drive articulated robots without any bulky components and connectors, which weigh down the robot and reduce portability and speed. Their slender and lightweight simple ...
LAST 30 PRESS RELEASES:
[Press-News.org] Early lung cancer coopts immune cell into helping tumors invade the lungs
